Replimune Group, Inc. IPO Research Information

Replimune Group, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Replimune Group, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Replimune Group, Inc.	REPL - NASDAQ	$14.00-$16.00	$15.00	$16.00	6.7 million	7/20/2018
Underwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-06-22 Terms Added 2018-07-10

Replimune Group, Inc. Quote & Chart - Click for current quote - REPL

About Replimune Group, Inc. (adapted from Replimune Group, Inc. prospectus):
They are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "REPL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.